Form 8-K - Current report:
SEC Accession No. 0001140361-25-005427
Filing Date
2025-02-21
Accepted
2025-02-21 16:20:40
Documents
16
Period of Report
2025-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20043949_8k.htm   iXBRL 8-K 35013
2 EXHIBIT 5.1 ef20043949_ex5-1.htm EX-5.1 13775
3 EXHIBIT 10.1 ef20043949_ex10-1.htm EX-10.1 225158
7 image0.jpg GRAPHIC 87668
  Complete submission text file 0001140361-25-005427.txt   592970

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bngo-20250221.xsd EX-101.SCH 4003
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20250221_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20250221_pre.xml EX-101.PRE 16058
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20043949_8k_htm.xml XML 4234
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25652216
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)